Wyva
Senior Member (Voting Rights)
Found an interview in English with Michael Stingl, Austrian neurologist who specializes in ME/CFS.
Long-Covid treatment: instead of inaction – use existing medication!
Long-Covid treatment: instead of inaction – use existing medication!
As a doctor, what do you need to better treat patients with ME/CFS and Long Covid?
The big problem with ME/CFS is that we don’t know the one underlying mechanism. We have to diagnose based on symptoms and there are probably different causes that cause a very similar clinical picture. I am involved in a project at the University of Vienna in which questionnaires are used to try to distinguish between clinical subtypes and to see what the possible causes are.
The therapies depend on that?
Yes. There are many hypotheses. That it could be an autoimmune reaction is one of them. Such antibodies are found in 30 to 70 percent of those affected. Whether they really have the basic pathophysiological relevance is not yet clear. But if you have auto-antibodies, for example, you could use BC007 [von Berlin Cures, Anm. d. Red.] help. If you don’t have autoantibodies, it doesn’t make sense.
If the studies show that BC007 works, then the pharmaceutical industry will take an interest. Then I’m reasonably optimistic that new medicines will be found in the next few years. This has also been seen in multiple sclerosis. 30 years ago you had nothing and now there are numerous drugs that can often stop this serious neuroimmunological disease.
Until then, are you treating with existing medications that you give off-label?
I don’t promise anyone salvation, I can’t. Normally, nothing makes the symptoms go away. But the point is simply that you can at least produce an improvement in performance. In the guideline of the Austrian Society for General Medicine there is now an addition to the Chronic Fatigue Syndrome, which basically contains what I am trying to do pragmatically. We cannot wait for evidence to be generated and meanwhile do nothing!
See this thread: Long Covid drug BC-007 research news
The therapies depend on that?
Yes. There are many hypotheses. That it could be an autoimmune reaction is one of them. Such antibodies are found in 30 to 70 percent of those affected. Whether they really have the basic pathophysiological relevance is not yet clear. But if you have auto-antibodies, for example, you could use BC007 [von Berlin Cures, Anm. d. Red.] help. If you don’t have autoantibodies, it doesn’t make sense.
If the studies show that BC007 works, then the pharmaceutical industry will take an interest. Then I’m reasonably optimistic that new medicines will be found in the next few years. This has also been seen in multiple sclerosis. 30 years ago you had nothing and now there are numerous drugs that can often stop this serious neuroimmunological disease.
Until then, are you treating with existing medications that you give off-label?
I don’t promise anyone salvation, I can’t. Normally, nothing makes the symptoms go away. But the point is simply that you can at least produce an improvement in performance. In the guideline of the Austrian Society for General Medicine there is now an addition to the Chronic Fatigue Syndrome, which basically contains what I am trying to do pragmatically. We cannot wait for evidence to be generated and meanwhile do nothing!
See this thread: Long Covid drug BC-007 research news
Last edited by a moderator: